Table 2: Clinical and biochemical characteristics at the start of the study and after 24 weeks of treatment.

VariablesTreatment Placebo value* value
Week 0Week 24Δ 24−0 weeksWeek 0Week 24Δ 24−0 weeks

Body weight (kg) 0.079, 0.7470.419
WC (cm) 0.000, 0.0010.890
Systolic BP (mmHg) 0.518, 0.7100.496
Diastolic BP (mmHg) 0.948, 0.7310.813
Fasting glucose (mg/dL) 0.499, 0.0110.229
AST (IU/L) 0.246, 0.0020.091
ALT (IU/L) 0.183, 0.0490.603
GGT (IU/L) 0.603, 0.3780.351
Creatinine (mg/dL) 0.290, 0.8270.658
Free testosterone (pg/mL) 0.135, 0.2350.055

AST: aspartate transaminase; ALT: alanine transaminase; BP: blood pressure; GGT: gamma-glutamyltransferase; WC: waist circumference.
Data are means ± SD. Δ 24-0 weeks and difference compared with baseline.
*Paired Student’s -test within group.
Two-way repeated measures ANOVA over time between groups.